(Q33643786)

28 July 2017

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity (English)

1 reference

28 July 2017

0 references

Shelly Gunn

1

1 reference

28 July 2017

I-Tien Yeh

2

1 reference

28 July 2017

Irina Lytvak

3

1 reference

28 July 2017

Budi Tirtorahardjo

4

1 reference

28 July 2017

Natasha Dzidic

5

1 reference

28 July 2017

Soheila Zadeh

6

1 reference

28 July 2017

Jaeweon Kim

7

1 reference

28 July 2017

Chris McCaskill

8

1 reference

28 July 2017

Lony Lim

9

1 reference

28 July 2017

Mercedes Gorre

10

1 reference

28 July 2017

Mansoor Mohammed

11

1 reference

28 July 2017

language of work or name

English

0 references

publication date

28 July 2010

1 reference

28 July 2017

1 reference

28 July 2017

10

1 reference

28 July 2017

396

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-396

28 July 2017

0 references

cites work

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

The vanguard has arrived in the clinical laboratory: array-based karyotyping for prognostic markers in chronic lymphocytic leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2915985

Standardization of HER2 testing: results of an international proficiency-testing ring study.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-396

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-396

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-10-396

How is Her-2/neu status established when Her-2/neu and chromosome 17 centromere are both amplified?

21 January 2018

1 reference

12 December 2020

Evaluation of Her-2/neu status in carcinomas with amplified chromosome 17 centromere locus

1 reference

12 December 2020

Inconsistency of HER2 test raises questions

1 reference

12 December 2020

Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification

1 reference

12 December 2020

The rewards and challenges of array-based karyotyping for clinical oncology applications

1 reference

12 December 2020

Be precise! The need to consider the mechanisms for CEP17 copy number changes in breast cancer

1 reference

12 December 2020

Prognostic relevance of gene amplifications and coamplifications in breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-396

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference